title: Rethinking risk-benefit assessment for phase I cancer trials.
authors.affiliation: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Steven
authors.initials: S
authors.lastname: Joffe
authors.forename: Franklin G
authors.initials: FG
authors.lastname: Miller
mesh_terms: D035843:Biomedical Research / Q000941:ethics; D017321:Clinical Trials, Phase I as Topic / Q000941:ethics*; D004992:Ethics, Medical; D006801:Humans; D009369:Neoplasms / Q000628:therapy; D012107:Research Design; D018570:Risk Assessment